Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05065905Phase 1Completed

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

Role: collaborator

NCT06175442Unknown

Effectiveness of Small Bowel Decompression Techniques in Patients With Small Bowel Obstruction

Role: lead

NCT05841069Not ApplicableUnknown

Short and Prolonged Conservative Treatment in Patients With Adhesive Intestinal Obstruction

Role: lead

NCT04002869Unknown

Innovation in Tuberculosis

Role: collaborator

NCT03415971Not ApplicableCompleted

Electromyographic Estimation of Neuro-muscular Coordination of Masticatory Muscles in Patients Treated With Implants (D-2012-057)

Role: lead

All 5 trials loaded